VCYT
VCYT
NASDAQ · Biotechnology

Veracyte Inc

$39.80
-0.78 (-1.91%)
As of Sep 20, 10:03 PM ET ·
Financial Highlights (FY 2026)
Revenue
503.70M
Net Income
64.63M
Gross Margin
70.1%
Profit Margin
12.8%
Rev Growth
+20.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 503.70M 418.46M 507.99M 466.85M
Gross Profit 353.09M 293.34M 340.77M 313.18M
Operating Income 56.26M 42.07M -2,427,180 -2,364,906
Net Income 64.63M 48.32M -2,027,984 -2,410,114
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Rev Growth +20.4% +20.4% +16.6% +7.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 875.10M 761.72M
Total Equity 1.67B 1.94B
D/E Ratio 0.52 0.39
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 63.98M 50.49M -2,983,128 -2,794,572
Free Cash Flow -1,866,923 -2,624,091